BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

37 related articles for article (PubMed ID: 36512100)

  • 1. A mixture-like model for tumor-immune system interactions.
    Fotso CT; Girel S; Anjuère F; Braud VM; Hubert F; Goudon T
    J Theor Biol; 2024 Mar; 581():111738. PubMed ID: 38278343
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Senescent Tumor Cells Build a Cytokine Shield in Colorectal Cancer.
    Choi YW; Kim YH; Oh SY; Suh KW; Kim YS; Lee GY; Yoon JE; Park SS; Lee YK; Park YJ; Kim HS; Park SH; Kim JH; Park TJ
    Adv Sci (Weinh); 2021 Feb; 8(4):2002497. PubMed ID: 33643790
    [TBL] [Abstract][Full Text] [Related]  

  • 3. T-helper 2 cytokines attenuate senescent eosinophil activation by the CXCR4 ligand stromal-derived factor-1alpha (CXCL12).
    Dulkys Y; Buschermöhle T; Escher SE; Kapp A; Elsner J
    Clin Exp Allergy; 2004 Oct; 34(10):1610-20. PubMed ID: 15479278
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dual blockade of CXCL12-CXCR4 and PD-1-PD-L1 pathways prolongs survival of ovarian tumor-bearing mice by prevention of immunosuppression in the tumor microenvironment.
    Zeng Y; Li B; Liang Y; Reeves PM; Qu X; Ran C; Liu Q; Callahan MV; Sluder AE; Gelfand JA; Chen H; Poznansky MC
    FASEB J; 2019 May; 33(5):6596-6608. PubMed ID: 30802149
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of senescent tumor cells in building a cytokine shield in the tumor microenvironment: mathematical modeling.
    Kim Y; Lee J; Lee C; Lawler S
    J Math Biol; 2022 Dec; 86(1):14. PubMed ID: 36512100
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Senescent tumor cells: an overlooked adversary in the battle against cancer.
    Park SS; Choi YW; Kim JH; Kim HS; Park TJ
    Exp Mol Med; 2021 Dec; 53(12):1834-1841. PubMed ID: 34916607
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CXCL12 Signaling in the Tumor Microenvironment.
    Portella L; Bello AM; Scala S
    Adv Exp Med Biol; 2021; 1302():51-70. PubMed ID: 34286441
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemokine Heterocomplexes and Cancer: A Novel Chapter to Be Written in Tumor Immunity.
    D'Agostino G; Cecchinato V; Uguccioni M
    Front Immunol; 2018; 9():2185. PubMed ID: 30319638
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cellular senescence and the tumour microenvironment.
    Takasugi M; Yoshida Y; Ohtani N
    Mol Oncol; 2022 Sep; 16(18):3333-3351. PubMed ID: 35674109
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CXCR4 and CXCR7 Signaling Pathways: A Focus on the Cross-Talk Between Cancer Cells and Tumor Microenvironment.
    Santagata S; Ieranò C; Trotta AM; Capiluongo A; Auletta F; Guardascione G; Scala S
    Front Oncol; 2021; 11():591386. PubMed ID: 33937018
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.